NeuroMetrix, Inc.
NURO
$4.34
-$0.035-0.80%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.04% | -1.36% | 50.89% | -83.67% | 6.74% |
| Total Depreciation and Amortization | -6.01% | -34.82% | 269.08% | -71.41% | 729.52% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -74.88% | 85.82% | -278.14% | 572.78% | -135.79% |
| Change in Net Operating Assets | 60.19% | -276.13% | -78.15% | 545.19% | 136.69% |
| Cash from Operations | -5.45% | -31.36% | 34.44% | -43.50% | 29.65% |
| Capital Expenditure | -- | -- | -- | -- | 67.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 116.23% | -35.22% | 1,135.65% | -3.56% | -92.02% |
| Cash from Investing | 116.23% | -35.22% | 1,135.65% | 41.12% | -94.09% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -99.82% | -9.41% | 115,892.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -99.82% | -9.41% | 115,892.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 173.86% | -297.55% | 173.52% | -273.91% | 167.45% |